1.
Nathan R. Hill STF, Jason L. Oke, Jennifer A. Hirst, Christopher A. O’Callaghan, Daniel
S. Lasserson, F. D. Richard Hobbs. Global prevalence of chronic kidney disease-A systematic
review and meta-analysis. PLoS one 2016;11:e0158765.
2. Samy I.McFarlane, Shu-ChengChen, Adam T.Whaley-Connell, James R.Sowers, Joseph
A.Vassalotti, Moro O.Salifu, et al. Prevalence and Associations of Anemia of CKD:
Kidney Early Evaluation Program(KEEP)and National Health and Nutrition Examination
Survey (NHANES)1999-2004. Am J Kidney Dis 2008;51(4):S46-S55.
3. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United
States. PLoS One 2014;9(1):e84943.
4. Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH, et al. The Prevalence and Management
of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study
for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci
2017;32(2):249-56.
5. Stanifer JW, MuiruA, Jafat TH, Patel UD. Chronic kidney disease in low- and middle-income
countries. Nephrol Dial Transplant 2016;31:868-874.
6. Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease
on the African continent: a systematic review and meta-analysis. BMC Nephrology 2018;19:125-136.
7. ElHafeez SA, Bolignano D, D'Arrigo G, Dounousi E, Tripepi G, Zocccali C. prevalence
and burden of chronic kidney disease among the general population and high-risk groups
in Africa:a systematic review. BMJ Open 2018;8:e015069.
8. Babitt JL, Lin HY. Mechanisms of Anemia in CKD. J Am Soc Nephrol 2012;23: 1631–34.
9. Rivera RF, Lullo LD, Pascalis AD, Floccari F, Joli G, Pezzini E, et.al. Anemia in patients with chronic kidney disease: current screening and management
approaches. Nephrol Renal Dis 2016;1(1):1-9
10. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S et.al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review
and meta-analysis. Lancet Glob Health 2014;2:e174-181.
11. Maina CK, Karimi PN, Mariita K, Nyamu DG, Mugendi GA, Opanga SA. Correlates and
management of anemia of chronic kidney disease in a Kenyan Tertiary hospita. East
Afri Med Journ 2016;93:10:489-499.
12. Amoako YA, Laryea DO, Beddu-Addo G, Andoh H, Awuku YA. Clinical and demographic
characteristics of chronic kidney disease patients in a tertiary facility in Ghana.
Pan Afric Med Journ 2014;18:274-284.
13. Fesiha T, Kassim M, Yemane T. Prevalence of chronic kidney disease and associated
risk factors among diabetic patients in Southern Ethiopia. American Journ of health
Res 2014;2(4):216-221.
14. Abate A, Birhan W, Alemu A. Association of anemia and renal function test among
diabetes mellitus patients attending Fenote Selam Hospital, West Gojam, Northwest
Ethiopia: a cross sectional study. BMC Hematology 2013;13(6).
15. He J, Shlipak M, Anderson A, Roy JA, Feldman HI, Kallem RR, et al. Risk Factors
for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal
Insufficiency Cohort) Study. J Am Heart Assoc 2017;6(5).
16. Bhatti S, Hakeem A, Dillie KS, Cook JR, Chang SM. Prevalence, prognosis, and therapeutic
implications of unrecognized left ventricular systolic dysfunction in patients with
anemia and chronic kidney disease. Congest Heart Fail 2010;16(6):271-7.
17. Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, et al.
Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney
disease: A nested case-control study. World J Nephrol 2016;5(4):358-66.
18. Wayne WD, Cross CL. Biostatistics: A foundation for analysis in health sciences.
10eds. John Wiley and Sons Ltd, NJ.2013.
19. WHO. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity.
WHO/NMH/NHD/MNM/11.1
20. KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation,
prevention, and treatment of chronic kidney disease. Kidney Internat Suppl 2017;7(1):1-59.
21. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et.al. Effect of blood pressure lowering and anti-hypertensive drug class on progression
of hypertensive drug class on progression of hypertensive kidney disease: results
from AASK trial. JAMA 2002;288(19):2421-31.
22. Daniel Eriksson DG, Siguroli Teitsson,James Jackson, Floortje van Nooten. Cross-sectional
survey in CKD patients across Europe describing the association between quality of
life and anaemia BMC Nephrology 2016;17(97 ).
23. Abramson JL, Jurkovitz CT,Vaccarino V, William S, Weintraub WM. Chronic kidney
disease, anemia, and incident stroke in a middle-aged, community-based population:The
ARIC Study. Kidney Internat 2003;64:610–5.
24. Del Fabbro P, Luthi J-C, Carrera E, Michel P, Burnier M, Burnand B. Anemia and chronic
kidney disease are potential risk factors for mortality in stroke patients: a historic
cohort study. BMC Nephrology 2010;11:27:1-10.
25. Iimori S, Naito S, Noda Y, Nishida H, Kihira H, Yui N, et al. Anaemia management
and mortality risk in newly visiting patients with chronic kidney disease in Japan:
The CKD-ROUTE study. Nephrology 2015;20(9):601-8.